CLOs on the Move


 
CORHIO is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Denver, CO. To find more information about CORHIO, please visit www.corhio.org
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.corhio.org
  • 3773 Cherry Creek North Dr Ste 615
    Denver, CO USA 80209-3868
  • Phone: 720.285.3200

Executives

Name Title Contact Details

Similar Companies

Meta Pharmaceutical Services

Meta Pharmaceutical Services is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NDRI National Disease Research Interchange

NDRI National Disease Research Interchange is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

BayStar EMS

BayStar EMS is a Baytown, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.

Emergent Health Corp.

Emergent Health Corp. is a public company (trading under the symbol EMGE) dedicated to the betterment of its shareholders and product consumers. We believe we have a developing product line to become a leader in the field of Regenerative Medicine and improved neutraceuticals and phytonutritionals to be available to the general public without a prescription.